Immunisation Coalition: HPV Update webinar recording
这 Immunisation Coalition HPV Update webinar was held on 13 March 2024, presented by Angela Newbound and moderated by Andrew Minton.
A recording of the webinar is now available on the Immunisation Coalition event page.
The Vaccine Coverage: MVEC’s new podcast is out!
MVEC has released the first two episodes of our new podcast, ‘The Vaccine Coverage’.
This series features conversations with special guests on a range of topics relating to vaccination in Australia.
The first two episodes cover vaccine myths, and how our body's respond when we receive a vaccine.
Listen on our website or search ‘The Vaccine Coverage’ in your favourite podcast app.
Updated immunisation reference page: Pneumococcal
Pneumococcal disease is a leading cause of serious illness in Australian children under 2 years and older Australians, and is responsible for over a million deaths worldwide every year.
Pneumococcal disease is caused by infection with the bacteria 肺炎链球菌. Symptoms vary depending on the site of infection; they may include fever, headache, earache and cough. Infection may result in meningitis (inflammation of the tissue surrounding the brain and spinal cord), pneumonia, septicaemia (blood infection) and osteomyelitis (bone infection), for example.
We have recently updated our pneumococcal reference page. The updated page includes more details on pneumococcal transmission and epidemiology, as well as detailed guidance on vaccine recommendations by age and risk category.
New publication: Analyzing an immunization resource website
Researchers from SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) recently published an article in ‘Vaccine’, analysing user browsing trends on the MVEC website.
Over a four-year period from 2019 to 2022, there was specific interest in vaccine-related topics corresponding with key vaccine topics like COVID-19 vaccine administration techniques and adverse events following immunisation.
Vaccine: Analyzing an immunization resource website: User browsing trends
NCIRS: Webinar – Shingrix
这 国家免疫研究和监测中心 (NCIRS) is hosting a webinar on Australia’s new National Immunisation Program (NIP) shingles (zoster) vaccine, Shingrix, to be held on Tuesday 7 November 2023 from 12:00 pm to 1:30 pm (AEDT).
Leading experts will present on:
- the disease burden of shingles in Australia
- details about Shingrix
- the new Australian Shingrix vaccination program
- the US experience of implementing a national Shingrix program.
ABC: Permanent funding for South Australian specialist immunisation service
SA Health will permanently fund the Women’s and Children’s Hospital’s specialist immunisation service, set up in 2021.
The unit supports patients with past trauma, neurodiverse conditions and needle phobia, offering sedation for vaccination and for minor medical procedures such as blood tests, dental check-ups and X-rays.
ABC: Needle phobia can impede jabs – but a hospital service is boosting vaccines and injections
NCIRS: Multiple vaccinations for children resource
这 国家免疫研究和监测中心 (NCIRS) has recently developed a new resource to support conversations about administering multiple vaccinations at the same time in children.
NCIRS: Multiple vaccinations for children resource
The Lancet: Surge of invasive group A strep in Australia
The Lancet recently published a study, analysing data from the Paediatric Active Enhanced Disease Surveillance (PAEDS) Networks, which shows Australia experienced an intense and unseasonal surge of invasive group A streptococcal disease in 2022.
The national research project involved researchers from Murdoch Children’s Research Institute, including MVEC Director Prof Nigel Crawford.
Read the study in full: Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges
维多利亚州卫生部：疫苗错误管理
维多利亚州卫生部最近推出了有关疫苗错误管理的新免疫资源。
该资源包括有关预防疫苗错误和最常见疫苗错误的易于理解的信息，以及向 SAEFVIC（社区疫苗接种后不良事件监测）报告疫苗错误的说明。
更新的参考页面：疫苗的开发和注册
与任何正在开发的药物一样，疫苗在获得许可和注册用于疫苗接种计划之前，必须经过严格的测试程序和科学评估，不仅要证明它们对目标疾病的影响，还要确定它们的安全性。
我们最新更新的疫苗开发和注册页面包括有关疫苗临床试验、许可后监测、注册和临时批准以及疫苗卫生经济学评估的信息。